Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
DOCK4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
CHML - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
VWA1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PPEF1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ACTG1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
DNAAF5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ANAPC4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LYAR - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PKNOX1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SUGT1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
TIMM17A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TUBB2B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MAST2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CEP83 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RABEPK - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CFAP36 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on